Asset Entities
Open
$15.29
Prev. Close
$15.30
High
$15.41
Low
$15.29
Market Snapshot
$587.56M
-1.5
-1.45
$679.5K
9
Strive Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Dallas, Texas and currently employs 9 full-time employees. The company went IPO on 2023-02-03. Strive, Inc. is an asset management Bitcoin treasury company. The firm is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The firm's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.
emptyResult
Strive Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Dallas, Texas and currently employs 9 full-time employees. The company went IPO on 2023-02-03. Strive, Inc. is an asset management Bitcoin treasury company. The firm is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The firm's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.